Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis
Abstract The use of proton therapy (PT) in early-stage non-small cell lung cancer (ES-NSCLC) remains controversial, with insufficient evidence to determine its superiority over photon therapy (XRT). We conducted a systematic review of PT trials in ES-NSCLC, analyzing dosimetry, efficacy, and safety...
| Published in: | Biomarker Research |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40364-024-00642-5 |
